Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes

Immunology

Volumn 90, Issue 3, 1997, Pages 440-447

  Bussolati, B ^a   Mariano, F ^a   Montrucchio, G ^a   Piccoli, G ^a   Camussi, G ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYCLOHEXIMIDE; INTERLEUKIN 10; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; SUPEROXIDE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CHEMOLUMINESCENCE; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031055248     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.1997.00440.x     Document Type: Article

References (40)

1. CAMUSSI G., MONTRUCCHIO G., DOMINIONI L. & DIONIGI R. (1995) Septic shock: the unravelling of molecular mechanisms. Nephrol Dial Transplant 10, 1808.
2. ANDERSON B.O., BENSARD D.D. & HARKEN A.H. (1991) The role of platelet-activating factor and its antagonists in shock, sepsis and multiple organ failure. Surg Gynecol Obstetr 172, 415.
3. BRAQUET P., TOUQUI L., SHEN T.Y. & VARGAFTIG B.B. (1987) Perspectives in platelet-activating factor research. Pharmacol Rev 39, 97.
4. BARNES P.J., PAGE C.P. & HENSON P. (1989) Platelet activating factor and human disease. Blackwell Scientific Publications, London.
5. MCMANUS L., WOODARD D.S., DEAVERS S.I. & PINCKARD R.N. (1993) Biology of disease: PAF molecular heterogeneity, pathobiological implications. Lab Invest 69, 639.
6. CHAO W. & OLSON M.S. (1993) Platelet activating factor receptors and signal transduction. J Biochem 292, 617.
7. LOPEZ DIEZ F., NIETO M.L., FERNANDEZ S., GALLARDO D., GIJON M.A. & SANCHEZ-CRESPO M. (1989) Occupancy of platelet receptors for platelet activating factor in patients with septicemia. J Clin Invest 83, 1733.
8. INARREA P., GOMEZ-CAMBRONERO J., PASCUAL J., PONTE M.D., HERNANDO L. & SANCHEZ-CRESPO M. (1985) Synthesis of PAF-acether and blood volume changes in gram-negative sepsis. Immunopharmacology 9, 45.
9. DOEBBER T.W., WU M.S., ROBBINS J.C., CHOY M.B., CHANG M.N. & SHEN T.Y. (1985) Platelet-activating factor involvement in endotoxin-induced hypotension in rats: studies with PAF-receptor antagonist Kadsurenone. Biochem Biophys Res Comun 127, 799.
10. WANG J. & DUNN M.J. (1987) Platelet activating factor mediates endotoxin-induced acute renal insufficiency in rats. Am J Physiol 253, F1.
11. MOORE K.W., O'GARRA A., DE WAAL MALEFYT R., VIEIRA P. & MOSMANN T.R. (1993) Interleukin-10. Annu Rev Immunol 11, 165.
12. DE WAAL MALEFYT R., ABRAMS J., BENNETT B., FIGDOR C.G. & DE VRIES J.E. (1991) Interleukin-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174, 1209.
13. CASSATELLA M.C., MEDA L., BONORA S., CESKA M. & CONSTANTIN G. (1993) Interleukin-10 inhibits the release of proin-flammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 178, 2207.
14. GAZZINELLI R.T., OSWALD I.P., JAMES S.L. & SHER A. (1992) IL-10 inhibits parasite killing and nitrogen oxide production by INF-γ activated macrophages. J Immunol 148, 1792.
15. BOGDAN C., VODOVOTZ Y. & NATHAN C. (1991) Macrophage deactivation by interleukin-10. J Exp Med 174, 1549.
16. HOWARD M., MUCHAMUEL T., ANDRADE S. & MENON S. (1993) Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 177, 1205.
17. GéRARD C., BRUYNS C., MARCHANT A. et al. (1993) Interleukin-10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177, 547.
18. 1-antichymotripsin and is stimulated by proteinases. J Exp Med 168, 1293.
19. VALONE F.H. & EPSTEIN L.B. (1988) Biphasic platelet-activating factor synthesis by human monocytes stimulated with IL-1 beta, tumor necrosis factor or IFN-gamma. J Immunol 141, 3945.
20. CAMUSSI G., BUSSOLINO F., SALVIDIO G. & BAGLIONI C. (1987) Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor. J Exp Med 166, 1390.
21. BUSSOLINO F., CAMUSSI G. & BAGLIONI C. (1988) Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-1. J Biol Chem 263, 1856.
22. BENVENISTE J., LE COUEDIC J.P., POLONSKY J. & TENCE M. (1977) Structural analysis of purified platelet-activating factor by lipases. Nature 269, 170.
23. SILVESTRO L., DA COL R., SCAPPATICCI E., LIBERTUCCI D., BIANCONE L. & CAMUSSI G. (1993) Development of an HPLC-MS technique, with an ionspray interface, for the determination of PAF and lyso-PAF in biological samples. J Chromatogr 647, 261.
24. ROVIN B.H., WURST E. & KOAN D.E. (1990) Production of reactive oxygen species by tubular epithelial cells in culture. Kidney Int 37, 1509.
25. DE LUCA M.A. & MCELROY W.D. (1973) Bioluminescence and Chemiluminescence. Academic Press, New York.
26. BLIGH E.G. & DYER W.J. (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37, 911.
27. CAMUSSI G., MARIANO F., DE MARTINO A., BUSSOLATI B., MONTRUCCHIO G. & TOBIAS P.S. (1995) Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. J Immunol 155, 316.
28. BAGGIOLINI M., WALTZ A. & KUNKEL S.L. (1989) Neutrophil-activing peptide-1/interleukin-8, a novel citokine that activates neutrophils. J Clin Invest 84, 1045.
29. BUSSOLINO F., SIRONI M., BOCCHIETTO E. & MANTOVANI A. (1992) Synthesis of Platelet-activating Factor by Polymorphonuclear Neutrophils stimulated with Interleukin-8. J Biol Chem 267, 1498.
30. WORTEN G.S., SECCOMBE J.F., CLAY K.L., GUTHRIE L.A. & JOHNSON R.B. (1988) The priming of neutrophils by Lypopolysaccharide for production of intracellular Platelet-activating Factor. J Immunol 140, 3553.
31. ZIEGLER-HEITBROCK H.W.L. & ULEVITCH R.J. (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14, 121.
32. WRIGHT S.D., RAMOS R.A., TOBIAS P.S., ULEVITCH R.J. & MATHISON J.C. (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431.
33. GEGNER J.A., ULEVITCH R.J. & TOBIAS P.S. (1995) Lipopolysaccharide (LPS) signal transduction and clearance. J Biol Chem 270, 5320.
34. VALONE F.H. & EPSTEIN L.B. (1988) Biphasic Platelet-activating factor synthesis by human Monocytes stimulated with IL-1β, Tumor Necrosis Factor or IFN-γ. J Immunol 141, 3945.
35. TRACEY K., VLASSARA H. & CERAMI A. (1989) Cachectin tumor necrosis factor. Lancet 20, 1122.
36. CAMUSSI G. (1994) Interactive effects of tumor necrosis factor and platelet activating factor in the pathogenesis of glomerular injury. Lab Invest 70, 435.
37. PUGIN J., RICHARD J.U. & TOBIAS P.S. (1993) A critical role for monocytes and CD14 in endotoxin-induced endothelial cells activation. J Exp Med 178, 2193.
38. BOGDAN C., PAIK J., VODOVOTS Y. & NATHAN C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267, 23301.
39. CASSATELLA M., MEDA L., GASPERINI S., CALZETTI F. & BONORA S. (1994) Interleukin-10 upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179, 1695.
40. MARSHALL J.S., LEAL-BERUMEN I., NIELSEN L., GLIBETIC M. & JORDANA M. (1996) Interleukin-10 inhibits long-term IL-6 production but not preformed release from rat peritoneal mast cells. (1996) J Clin Invest 97, 1122.